Guardian Pharmacy Services, Inc.
GRDN Healthcare Medical Care Facilities
Guardian Pharmacy Services, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.4 billion, up 17.9% from fiscal 2024.
- Revenue
- −1.68%
- EPS
- +133.3%
- Free cash flow
- +88.9%
Quarter to September 2026, against a year earlier
Follow GRDN
Alert me
Guardian Pharmacy Services, Inc. (GRDN) Current ratio
Guardian Pharmacy Services, Inc.'s current ratio at the end of the quarter to 30 September 2026 was 1.6×, up 0.3× from fiscal 2025 (1.4×). That is above the Medical Care Facilities industry median of 1.4× and below the Healthcare sector median of 3.1×.
Current ratio, annual
Embed this chart
Annual newest first
| Period | Current ratio | Change |
|---|---|---|
| FY2025 | 1.4× | 30.78% |
| FY2024 | 1.1× | 12.30% |
| FY2023 | 0.9× | — |
Quarterly newest first
| Period | Current ratio | Change |
|---|---|---|
| Sep 2026 | 1.6× | (0.42%) |
| Jun 2026 | 1.7× | 12.85% |
| Mar 2026 | 1.5× | 6.21% |
| Dec 2025 | 1.4× | 12.65% |
| 5 more quarters | Free account |
Current ratio against peers
| Company | Current ratio |
|---|---|
| SGRY Surgery Partners, Inc. compare | 1.9× |
| GRDN Guardian Pharmacy Services, Inc. | 1.6× |
| ADUS Addus HomeCare Corporation compare | 1.6× |
| ACHC Acadia Healthcare Company, Inc. compare | 1.6× |
| NHC National HealthCare Corporation compare | 1.5× |
| MD Pediatrix Medical Group, Inc. compare | 1.3× |
| ASTH Astrana Health, Inc. compare | 1.2× |
| AVAH Aveanna Healthcare Holdings Inc. compare | 1.2× |
| BKD Brookdale Senior Living Inc. compare | 1.1× |
| Medical Care Facilities industry median | 1.4× |
| Healthcare sector median | 3.1× |
| Market median | 1.6× |
What Current ratio is
Current Ratio shows whether a company’s short-term assets are enough to cover the bills and debts it must pay within the next year.
Current Assets (Total) ÷ Current Liabilities (Total)
More on GRDN
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on invested capital
- Debt to equity
- Shares outstanding
- Book value per share
- The full statement